- Acquisition adds patient feedback and outcomes data to Radar Healthcare’s compliance software suite
- Deal comes soon after Radar Healthcare’s buyout of consent platform EIDO Healthcare
- Merger extends Radar Healthcare’s reach into Australia, New Zealand and the Middle East
Marlin Equity Partners’ portfolio company Radar Healthcare has acquired Cemplicity, a patient experience and patient-reported outcomes platform, in an add-on deal. Cemplicity will merge with Radar Healthcare, which provides risk, quality and compliance software for the healthcare and social care sectors.
The acquisition adds capabilities in patient-reported experience measures, patient-reported outcome measures, real-time patient feedback, shared decision-making insights, surgical site inspection surveillance, service recovery feedback and post-care outcomes to Radar Healthcare’s platform.
The deal follows Radar Healthcare’s recent acquisition of EIDO Healthcare, a digital consent and patient information provider. The combined business extends Radar Healthcare’s international footprint through Cemplicity’s operations in Australia and New Zealand, alongside a presence in the Middle East and the UK.
The combined platforms are designed to connect patient voice, experience and outcomes data with governance and improvement workflows, according to the companies, helping healthcare organizations identify risks earlier and reduce avoidable harm.
Marlin Equity Partners is an investment firm focused on software, technology and services, with nearly $10 billion in capital commitments and more than 270 acquisitions completed since its founding in 2005.
Financial terms of the transaction were not disclosed.
Editor’s note: This news brief was produced with the assistance of artificial intelligence.